Highlights and Quick Summary
- Average Receivables for the quarter ending February 28, 2023 was $21.5 Million (a -1.74% decrease compared to previous quarter)
- Year-over-year quarterly Average Receivables increased by 5.07%
- Annual Average Receivables for 2022 was $26.6 Million (a 81.01% increase from previous year)
- Annual Average Receivables for 2021 was $14.7 Million (a 14.06% increase from previous year)
- Annual Average Receivables for 2020 was $12.9 Million (a 60.31% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Receivables of Organigram Holdings Inc.
Most recent Average Receivablesof OGI including historical data for past 10 years.Interactive Chart of Average Receivables of Organigram Holdings Inc.
Organigram Holdings Inc. Average Receivables for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $21.49 | – | – | – | – |
| 2022 | $21.87 | $26.62 | $20.46 | $13.99 | $26.62 |
| 2021 | $16.11 | $14.71 | $11.5 | $12.92 | $14.71 |
| 2020 | $13.6 | $12.9 | $11.54 | $18.61 | $12.9 |
| 2019 | $13.51 | $8.04 | $11.54 | $18.61 | $8.04 |
| 2018 | – | – | $13.51 | $8.04 | $3.07 |
| 2017 | – | – | – | – | $2.2 |
| 2016 | – | – | – | – | $2.2 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic